690 related articles for article (PubMed ID: 31446382)
21. Demographic and clinical characteristics of lithium-treated older adults with bipolar disorder.
Forlenza OV; Hajek T; Almeida OP; Beunders AJM; Blumberg HP; Briggs FBS; De-Paula VJR; Dols A; Eyler LT; Forester BP; Gildengers A; Jimenez E; Korten NCM; Lafer B; McWhinney SR; Mulsant B; Rej S; Sarna K; Schouws S; Sutherland A; Tsai S; Vieta E; Yala J; Sajatovic M;
Acta Psychiatr Scand; 2022 Nov; 146(5):442-455. PubMed ID: 35837985
[TBL] [Abstract][Full Text] [Related]
22. What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier?
Faedda GL; Marangoni C
CNS Spectr; 2017 Apr; 22(2):120-125. PubMed ID: 27831463
[TBL] [Abstract][Full Text] [Related]
23. Current psychotropic medication prescribing patterns in late-life bipolar disorder.
Rej S; Herrmann N; Shulman K; Fischer HD; Fung K; Gruneir A
Int J Geriatr Psychiatry; 2017 Dec; 32(12):1459-1465. PubMed ID: 27911003
[TBL] [Abstract][Full Text] [Related]
24. Lithium treatment versus hospitalization in bipolar disorder and major depression patients.
Pompili M; Berardelli I; Sarubbi S; Rogante E; Germano L; Sarli G; Erbuto D; Baldessarini RJ
J Affect Disord; 2023 Nov; 340():245-249. PubMed ID: 37557990
[TBL] [Abstract][Full Text] [Related]
25. Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder.
Brunkhorst-Kanaan N; Klatt-Schreiner K; Hackel J; Schröter K; Trautmann S; Hahnefeld L; Wicker S; Reif A; Thomas D; Geisslinger G; Kittel-Schneider S; Tegeder I
Metabolism; 2019 Jun; 95():65-76. PubMed ID: 30954559
[TBL] [Abstract][Full Text] [Related]
26. Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study.
Hoertel N; Jaffré C; Pascal de Raykeer R; McMahon K; Barrière S; Blumenstock Y; Portefaix C; Raucher-Chéné D; Béra-Potelle C; Cuervo-Lombard C; Chevance A; Guerin-Langlois C; Lemogne C; Airagnes G; Peyre H; Kaladjian A; Limosin F;
J Affect Disord; 2019 May; 251():60-70. PubMed ID: 30904777
[TBL] [Abstract][Full Text] [Related]
27. Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.
Damba JJ; Bodenstein K; Lavin P; Drury J; Sekhon H; Renoux C; Trinh E; Rej S; Greenway KT
CNS Drugs; 2022 Oct; 36(10):1049-1077. PubMed ID: 36161425
[TBL] [Abstract][Full Text] [Related]
28. Medical comorbidity, acute medical care use in late-life bipolar disorder: a comparison of lithium, valproate, and other pharmacotherapies.
Rej S; Yu C; Shulman K; Herrmann N; Fischer HD; Fung K; Gruneir A
Gen Hosp Psychiatry; 2015; 37(6):528-32. PubMed ID: 26254672
[TBL] [Abstract][Full Text] [Related]
29. Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study.
Woo YS; Yoon BH; Song JH; Seo JS; Nam B; Lee K; Lee J; Jung YE; Kim MD; Lee JG; Wang SM; Kwon YJ; Bahk WM
PLoS One; 2020; 15(1):e0227217. PubMed ID: 31923220
[TBL] [Abstract][Full Text] [Related]
30. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinical characteristics of bipolar and depressive disorders in Korean clinical sample of youth: a retrospective chart review.
Shon SH; Joo Y; Park J; Youngstrom EA; Kim HW
Eur Child Adolesc Psychiatry; 2014 May; 23(5):307-16. PubMed ID: 23963644
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
[TBL] [Abstract][Full Text] [Related]
33. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
[TBL] [Abstract][Full Text] [Related]
34. Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort.
Lambert CG; Mazurie AJ; Lauve NR; Hurwitz NG; Young SS; Obenchain RL; Hengartner NW; Perkins DJ; Tohen M; Kerner B
Bipolar Disord; 2016 May; 18(3):247-60. PubMed ID: 27226264
[TBL] [Abstract][Full Text] [Related]
35. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
Sylvia LG; Shelton RC; Kemp DE; Bernstein EE; Friedman ES; Brody BD; McElroy SL; Singh V; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Thase ME; Reilly-Harrington NA; Nierenberg AA; Rabideau DJ; Kinrys G; Kocsis JH; Bobo WV; Kamali M; McInnis MG; Calabrese JR
Bipolar Disord; 2015 Mar; 17(2):212-23. PubMed ID: 25130321
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
Amsterdam JD; Shults J
Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
[TBL] [Abstract][Full Text] [Related]
37. Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders.
Ayyagari R; Thomason D; Mu F; Philbin M; Carroll B
J Med Econ; 2020 Feb; 23(2):204-212. PubMed ID: 31663802
[No Abstract] [Full Text] [Related]
38. Test-retest reliability of a new questionnaire for the retrospective assessment of long-term lithium use in bipolar disorder.
Tighe SK; Ritchey M; Schweizer B; Goes FS; MacKinnon D; Mondimore F; Raymond DePaulo J; McMahon FJ; Schulze TG; Zandi PP; Potash JB
J Affect Disord; 2015 Mar; 174():589-93. PubMed ID: 25562671
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders.
Nestsiarovich A; Mazurie AJ; Hurwitz NG; Kerner B; Nelson SJ; Crisanti AS; Tohen M; Krall RL; Perkins DJ; Lambert CG
Bipolar Disord; 2018 Dec; 20(8):761-771. PubMed ID: 29920885
[TBL] [Abstract][Full Text] [Related]
40. [Key points for the treatment of the elderly with bipolar disorder].
Dols A; van Gerven H; Oostervink F; Schouws S; Tolner I; Kupka RW; Stek ML
Tijdschr Psychiatr; 2012; 54(1):75-80. PubMed ID: 22237613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
